Compounds > edaravone
Page last updated: 2024-10-30

edaravone and Metabolic Syndrome

edaravone has been researched along with Metabolic Syndrome in 1 studies

Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaneko, K1
Yonemitsu, Y1
Fujii, T1
Onimaru, M1
Jin, CH1
Inoue, M1
Hasegawa, M1
Onohara, T1
Maehara, Y1
Sueishi, K1

Other Studies

1 other study available for edaravone and Metabolic Syndrome

ArticleYear
A free radical scavenger but not FGF-2-mediated angiogenic therapy rescues myonephropathic metabolic syndrome in severe hindlimb ischemia.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:4

    Topics: Angiogenesis Inducing Agents; Animals; Antipyrine; Edaravone; Fibroblast Growth Factor 2; Free Radic

2006